Position in ALLO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,418,000
+$1,617,655 QoQ
Shares Held
3,450,000
-30.5% QoQ
Ownership
1.000%
of shares outstanding
% of Portfolio
1.49%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Patient Square Capital LP holds $541,382,392 across 26 Biotechnology names. ALLO ranks #17 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
8,166,047 | $226,199,501 | |
| 2 | ARGX |
Argenx SE
|
36,718 | $26,813,319 | |
| 3 | INSM |
INSMED Inc
|
157,500 | $25,754,400 | |
| 4 | ONC |
BeOne Medicines Ltd.
|
80,542 | $23,918,557 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
596,000 | $22,940,040 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
230,000 | $21,247,400 | |
| 7 | BLTE |
Belite Bio, Inc
|
116,684 | $18,604,096 | |
| 8 | LEGN |
Legend Biotech Corp
|
990,000 | $17,909,100 |
All Filings in ALLO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,418,000 | 3,450,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,800,345 | 4,963,756 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,696,931 | 2,981,396 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,977,550 | 2,635,000 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,457,551 | 2,368,186 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,173,506 | 1,489,909 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||